Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa.
AUTOR(ES)
Jakics, E B
RESUMO
Seven spontaneous norfloxacin (NFLX)-resistant mutants obtained in vitro from 20 NFLX-susceptible clinical isolates and 3 NFLX-resistant clinical isolates of Pseudomonas aeruginosa were transformed with the pNF111 plasmid, whose BamHI fragment is responsible for conferring susceptibility to NFLX, by complementing the nfxB mutation. The resulting patterns of MICs of NFLX, beta-lactams, aminoglycosides, and chloramphenicol and the observed increased accumulation of NFLX were consistent with the occurrence of the nfxB type mutation in these clinical isolates.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=284377Documentos Relacionados
- Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa.
- Purification and characterization of the Pseudomonas aeruginosa NfxB protein, the negative regulator of the nfxB gene.
- nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa.
- Hypersusceptibility of the Pseudomonas aeruginosa nfxB Mutant to β-Lactams Due to Reduced Expression of the AmpC β-Lactamase
- Exotoxin production by clinical isolates of pseudomonas aeruginosa.
